Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm

The World Health Organisation (WHO) classifies myeloproliferative neoplasm (MPN) into BCR-ABL positive chronic myeloid leukaemia (CML Ph(+)) and Ph(−) MPN. The JAK2 V617F mutation is specific for Ph(−) MPN and occurs in approximately 50% of primary myelofibrosis. Earlier reports suggest that the occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Abdulaziz, Dogara, Livingstone Gayus, Babadoko, Ahmadu Aliyu, Awwalu, Sani, Mamman, Aisha Indo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314867/
https://www.ncbi.nlm.nih.gov/pubmed/25657500
http://dx.doi.org/10.4103/0300-1652.149177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314867/
https://www.ncbi.nlm.nih.gov/pubmed/25657500
http://dx.doi.org/10.4103/0300-1652.149177

Ejemplares similares